1 |
Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA 2020; 323: 1239-42.
DOI
|
2 |
Broderick G, Fuite J, Kreitz A, Vernon SD, Klimas N, Fletcher MA. A formal analysis of cytokine networks in chronic fatigue syndrome. Brain Behav Immun 2010; 24: 1209-17.
DOI
|
3 |
Yalcin HC, Sukumaran V, Al-Ruweidi MKAA, Shurbaji S. Do changes in ACE-2 expression affect SARS-CoV-2 virulence and related complications: a closer look into membranebound and soluble forms. Int J Mol Sci 2021; 22: 6703.
DOI
|
4 |
To KF, Lo AW. Exploring the pathogenesis of severe acute respiratory syndrome (SARS): the tissue distribution of the coronavirus (SARS-CoV) and its putative receptor, angiotensin-converting enzyme 2 (ACE2). J Pathol 2004; 203: 740-3.
DOI
|
5 |
Trouvin AP, Perrot S. New concepts of pain. Best Pract Res Clin Rheumatol 2019; 33: 101415.
DOI
|
6 |
Zhu J, Zhong Z, Ji P, Li H, Li B, Pang J, et al. Clinicopatho-logical characteristics of 8697 patients with COVID-19 in China: a meta-analysis. Fam Med Community Health 2020; 8: e000406. Erratum in: Fam Med Community Health 2020; 8: e000406corr1.
DOI
|
7 |
Lechien JR, Chiesa-Estomba CM, De Siati DR, Horoi M, Le Bon SD, Rodriguez A, et al. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study. Eur Arch Otorhinolaryngol 2020; 277: 2251-61.
DOI
|
8 |
Lechien JR, Chiesa-Estomba CM, Place S, Van Laethem Y, Cabaraux P, Mat Q, et al. Clinical and epidemiological characteristics of 1420 European patients with mild-to-moderate coronavirus disease 2019. J Intern Med 2020; 288: 335-44.
DOI
|
9 |
Attal N, Martinez V, Bouhassira D. Potential for increased prevalence of neuropathic pain after the COVID-19 pandemic. Pain Rep 2021; 6: e884.
DOI
|
10 |
Gan EY, Tian EA, Tey HL. Management of herpes zoster and post-herpetic neuralgia. Am J Clin Dermatol 2013; 14: 77-85.
DOI
|
11 |
Agyeman AA, Chin KL, Landersdorfer CB, Liew D, Ofori-Asenso R. Smell and taste dysfunction in patients with CO-VID-19: a systematic review and meta-analysis. Mayo Clin Proc 2020; 95: 1621-31.
DOI
|
12 |
Chung TW, Sridhar S, Zhang AJ, Chan KH, Li HL, Wong FK, et al. Olfactory dysfunction in coronavirus disease 2019 patients: observational cohort study and systematic review. Open Forum Infect Dis 2020; 7: ofaa199.
DOI
|
13 |
Varga Z, Flammer AJ, Steiger P, Haberecker M, Andermatt R, Zinkernagel AS, et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet 2020; 395: 1417-8.
DOI
|
14 |
Uygun O, Ertas M, Ekizoglu E, Bolay H, Ozge A, Kocasoy Orhan E, et al. Headache characteristics in COVID-19 pandemic-a survey study. J Headache Pain 2020; 21: 121
DOI
|
15 |
Pinzon RT, Wijaya VO, Buana RB, Al Jody A, Nunsio PN. Neurologic characteristics in coronavirus disease 2019 (COV-ID-19): a systematic review and meta-analysis. Front Neurol 2020; 11: 565.
DOI
|
16 |
Cucinotta D, Vanelli M. WHO declares COVID-19 a pandemic. Acta Biomed 2020; 91: 157-60.
|
17 |
Corsini Campioli C, Cano Cevallos E, Assi M, Patel R, Binnicker MJ, O'Horo JC. Clinical predictors and timing of cessation of viral RNA shedding in patients with COVID-19. J Clin Virol 2020; 130: 104577.
DOI
|
18 |
Aksan F, Nelson EA, Swedish KA. A COVID-19 patient with intense burning pain. J Neurovirol 2020; 26: 800-1.
DOI
|
19 |
Bolay H, Gul A, Baykan B. COVID-19 is a real headache! Headache 2020; 60: 1415-21.
DOI
|
20 |
National Institute for Health and Care Excellence (NICE); Royal College of General Practitioners; Healthcare Improvement Scotland, Scottish Intercollegiate Guidelines Network (SIGN). COVID-19 rapid guideline: managing the long-term effects of COVID-19 [Internet]. London: National Institute for Health and Care Excellence; 2020. Available at: www.nice.org.uk/guidance/ng188.
|
21 |
Ackermann M, Verleden SE, Kuehnel M, Haverich A, Welte T, Laenger F, et al. Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19. N Engl J Med 2020; 383: 120-8.
DOI
|
22 |
Grichnik KP, Ferrante FM. The difference between acute and chronic pain. Mt Sinai J Med 1991; 58: 217-20.
|
23 |
Garg P, Arora U, Kumar A, Wig N. The "post-COVID" syndrome: how deep is the damage? J Med Virol 2021; 93: 673-4.
DOI
|
24 |
Pons S, Fodil S, Azoulay E, Zafrani L. The vascular endothelium: the cornerstone of organ dysfunction in severe SARS-CoV-2 infection. Crit Care 2020; 24: 353.
DOI
|
25 |
Paliwal VK, Garg RK, Gupta A, Tejan N. Neuromuscular presentations in patients with COVID-19. Neurol Sci 2020; 41: 3039-56.
DOI
|
26 |
Treede RD, Rief W, Barke A, Aziz Q, Bennett MI, Benoliel R, et al. A classification of chronic pain for ICD-11. Pain 2015; 156: 1003-7.
DOI
|
27 |
Campbell WI, Lewis S. Visual analogue measurement of pain. Ulster Med J 1990; 59: 149-54.
|
28 |
Li LQ, Huang T, Wang YQ, Wang ZP, Liang Y, Huang TB, et al. COVID-19 patients' clinical characteristics, discharge rate, and fatality rate of meta-analysis. J Med Virol 2020; 92: 577-83.
DOI
|